NO20042890L - Pharmaceutical preparations and processes for their preparation - Google Patents

Pharmaceutical preparations and processes for their preparation

Info

Publication number
NO20042890L
NO20042890L NO20042890A NO20042890A NO20042890L NO 20042890 L NO20042890 L NO 20042890L NO 20042890 A NO20042890 A NO 20042890A NO 20042890 A NO20042890 A NO 20042890A NO 20042890 L NO20042890 L NO 20042890L
Authority
NO
Norway
Prior art keywords
processes
preparation
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
NO20042890A
Other languages
Norwegian (no)
Inventor
Ramachandran Thembalath
Yatish Kumar Bansal
Subhrangshu Sengupta
Nivendita Sing
Original Assignee
Ipca Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipca Lab Ltd filed Critical Ipca Lab Ltd
Publication of NO20042890L publication Critical patent/NO20042890L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20042890A 2003-02-05 2004-07-07 Pharmaceutical preparations and processes for their preparation NO20042890L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN151MU2003 2003-02-05
PCT/IN2003/000312 WO2004069234A1 (en) 2003-02-05 2003-09-17 Pharmaceutical compositions and process of production thereof

Publications (1)

Publication Number Publication Date
NO20042890L true NO20042890L (en) 2004-07-07

Family

ID=32843822

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042890A NO20042890L (en) 2003-02-05 2004-07-07 Pharmaceutical preparations and processes for their preparation

Country Status (4)

Country Link
EP (1) EP1589957A1 (en)
AU (1) AU2003282375A1 (en)
NO (1) NO20042890L (en)
WO (1) WO2004069234A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070092573A1 (en) * 2005-10-24 2007-04-26 Laxminarayan Joshi Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist
PL204780B1 (en) * 2006-06-02 2010-02-26 Zak & Lstrok Ady Farmaceutyczn Coated tablet containing carbomer for extended release of indapamid, which release profile is adjusted exactly during the coating process
PL2255791T3 (en) * 2009-04-03 2012-05-31 Zakl Farmaceutyczne Polpharma Sa Extended release pharmaceutical composition comprising metoprolol succinate
CN102008456B (en) * 2009-09-04 2015-01-14 鲁南制药集团股份有限公司 Novel skeleton sustained release tablet containing metoprolol succinate
IL210279A0 (en) 2009-12-25 2011-03-31 Dexcel Pharma Technologies Ltd Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients
CN102085195A (en) * 2011-01-10 2011-06-08 中国药科大学 Metoprolol succinate sustained-release tablets and preparation method thereof
HUE055974T2 (en) 2015-03-03 2022-01-28 Saniona As Combination of tesofensine and metoprolol
ES2924236T3 (en) * 2017-05-02 2022-10-05 Lubrizol Advanced Mat Inc Improved Extended Release Highly Loaded Pharmaceutical Compositions
WO2020144146A1 (en) 2019-01-07 2020-07-16 Saniona A/S Tesofensine for reduction of body weight in prader-willi patients
MX2022013236A (en) 2020-04-22 2023-01-24 Saniona As TREATMENT OF HYPOTHALAMIC OBESITY.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE457505B (en) * 1984-01-10 1989-01-09 Lejus Medical Ab LAMINATED ORAL PHARMACEUTICAL COMPOSITION AND PROCEDURES FOR ITS PREPARATION
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
US5019302A (en) * 1986-03-12 1991-05-28 Washington University Technology Associates, Inc. Method for granulation
SE0100200D0 (en) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating

Also Published As

Publication number Publication date
AU2003282375A1 (en) 2004-08-30
EP1589957A1 (en) 2005-11-02
WO2004069234A1 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
KR20050009999A (en) Pharmaceutical preparations
NO20044192L (en) 17alpha-alkyl-17beta-oxy-ostratrienes and pharmaceutical preparations
DK1673349T3 (en) Benzimidazole derivatives: preparation and pharmaceutical applications
NO20033556D0 (en) Pharmaceutical preparations
IS7948A (en) Phosphonooxyquinazoline derivatives and their pharmaceutical uses
IS3007B (en) Immunosuppressants and preparations
MA28489B1 (en) PHARMACEUTICAL PREPARATIONS
EE200300369A (en) Acylated indanylamines, process for their preparation, use and pharmaceutical preparation
NO20053817D0 (en) Preparations and Methods for Antiviral Combination Therapy.
IL164021A (en) Anti-αvβ6 antibodies and their pharmaceutical preparations
NO20054681D0 (en) Pharmaceutical products
PT1501534E (en) PHARMACEUTICAL FORMULATIONS
DK1511734T3 (en) Compounds, Preparations and Methods
IL169818A0 (en) Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
DK1560826T3 (en) Pyridopyrimidinone Derivatives, Processes for their Preparation and Pharmaceutical Compositions Containing These
DK1590321T3 (en) Arylalkylcarbamate derivatives, preparation and therapeutic use thereof
IS8422A (en) Benzimidazole derivatives, preparations containing them, their preparation and their use
DE502004002225D1 (en) Self-emulsifying preparations
NO20055173D0 (en) Pharmaceutical combination combination comprising modafinil and another drug
IS8219A (en) Benzimidazole derivatives, preparations containing them, their preparation and use
NO20052794D0 (en) Antibacterial indoloxazolidinone intermediates for their preparation and pharmaceutical preparations containing them
NO20043333L (en) Pharmaceutical parvastatin formulations and methods for their use
IS7266A (en) Pharmaceutical forms containing acid-intolerant active substances and methods for their preparation
IS7798A (en) Compounds, pharmaceutical preparations and methods
DE60328119D1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING MODAFINIL

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application